This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Sep;90(3):471-4.

doi: 10.1038/clpt.2011.149. Epub 2011 Jul 27.

Essential pharmacokinetic information for drug dosage decisions: a concise visual presentation in the drug label

D Menon-Andersen¹, B Yu, R Madabushi, V Bhattaram, W Hao, R S Uppoor, M Mehta, L Lesko, R Temple, N Stockbridge, T Laughren, J V Gobburu

Affiliations

PMID: 21796114
DOI: 10.1038/clpt.2011.149

Essential pharmacokinetic information for drug dosage decisions: a concise visual presentation in the drug label

D Menon-Andersen et al. Clin Pharmacol Ther. 2011 Sep.

. 2011 Sep;90(3):471-4.

doi: 10.1038/clpt.2011.149. Epub 2011 Jul 27.

Authors

D Menon-Andersen¹, B Yu, R Madabushi, V Bhattaram, W Hao, R S Uppoor, M Mehta, L Lesko, R Temple, N Stockbridge, T Laughren, J V Gobburu

Affiliation

¹ Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

PMID: 21796114
DOI: 10.1038/clpt.2011.149

No abstract available

PubMed Disclaimer

Similar articles

What are the important drug use errors in dialysis patients? Pharmacokinetic and pharmacodynamic principles.
Dager WE. Dager WE. Semin Dial. 2010 Sep-Oct;23(5):466-9. doi: 10.1111/j.1525-139x.2010.00773.x. Semin Dial. 2010. PMID: 21069914 Review. No abstract available.
Use of the MDRD study equation to estimate kidney function for drug dosing.
Stevens LA, Levey AS. Stevens LA, et al. Clin Pharmacol Ther. 2009 Nov;86(5):465-7. doi: 10.1038/clpt.2009.124. Clin Pharmacol Ther. 2009. PMID: 19844220 No abstract available.
Pharmacokinetic-pharmacodynamic relationship.
Baggot JD. Baggot JD. Ann Rech Vet. 1990;21 Suppl 1:29S-40S. Ann Rech Vet. 1990. PMID: 2080844 Review.
Optimizing drug development and use in patients with kidney disease.
Nolin TD, Arya V, Sitar DS, Pfister M. Nolin TD, et al. J Clin Pharmacol. 2011 May;51(5):628-30. doi: 10.1177/0091270011402500. J Clin Pharmacol. 2011. PMID: 21525394 No abstract available.
Pharmacokinetic changes in critical illness.
Boucher BA, Wood GC, Swanson JM. Boucher BA, et al. Crit Care Clin. 2006 Apr;22(2):255-71, vi. doi: 10.1016/j.ccc.2006.02.011. Crit Care Clin. 2006. PMID: 16677999 Review.

See all similar articles

Cited by

Population pharmacokinetic and exposure simulation analysis for cediranib (AZD2171) in pooled Phase I/II studies in patients with cancer.
Li J, Al-Huniti N, Henningsson A, Tang W, Masson E. Li J, et al. Br J Clin Pharmacol. 2017 Aug;83(8):1723-1733. doi: 10.1111/bcp.13266. Epub 2017 Mar 27. Br J Clin Pharmacol. 2017. PMID: 28213941 Free PMC article.
Using forest plots to interpret covariate effects in pharmacometric models.
Jonsson EN, Nyberg J. Jonsson EN, et al. CPT Pharmacometrics Syst Pharmacol. 2024 May;13(5):743-758. doi: 10.1002/psp4.13116. Epub 2024 Feb 28. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38415822 Free PMC article.
Using Fisher Information Matrix to predict uncertainty in covariate effects and power to detect their relevance in Non-Linear Mixed Effect Models in pharmacometrics.
Fayette L, Brendel K, Mentré F. Fayette L, et al. J Pharmacokinet Pharmacodyn. 2025 Jul 14;52(4):38. doi: 10.1007/s10928-025-09987-2. J Pharmacokinet Pharmacodyn. 2025. PMID: 40659916
Evaluation of covariate effects using forest plots and introduction to the coveffectsplot R package.
Marier JF, Teuscher N, Mouksassi MS. Marier JF, et al. CPT Pharmacometrics Syst Pharmacol. 2022 Oct;11(10):1283-1293. doi: 10.1002/psp4.12829. Epub 2022 Jun 27. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35670230 Free PMC article.
Ethnicity-Specific Drug Safety Data in European Medicines Agency Registration Dossiers, European Public Assessment Reports, and European and Singapore Drug Labels: Lost in Translation?
Maliepaard M, Taams AC, Sung C, Poh J, Yu Y. Maliepaard M, et al. Pharmaceut Med. 2019 Oct;33(5):407-416. doi: 10.1007/s40290-019-00302-2. Pharmaceut Med. 2019. PMID: 31933229

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information